Healthy Clinical Trial
Official title:
Early Learning and Development Project
Verified date | March 30, 2015 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will explore how babies become able to use their experience with objects to plan
to manipulate them appropriately. For example, an adult knows that picking up a grocery bag
full of canned food requires different actions than are needed for lifting an empty bag. This
study will examine when and how infants first begin to adapt their actions to manipulate
specific objects that weigh different amounts.
Participants will include normal healthy babies within 2 weeks of their first birthday. If
the expected results are obtained from testing, 9-month-old children will then be studied to
identify a lower age boundary in task performance. If the expected results are not obtained
at the 12-month test age, older children will be recruited to participate.
The study involves one 30-minute session with the baby and his or her mother or father. The
parent will answer some questions about the family, such as its size and ethnic make-up. The
infant will then have small magnetic sensors taped to the underside of each arm and to the
back. While sitting on the parent s lap, the infant will be presented with plastic toys, and
his or her actions will be measured by the sensors as he or she reaches for and picks up the
toys. The sensors will be connected to a computer that will track and record the motion of
the infant s arms.
...
Status | Completed |
Enrollment | 350 |
Est. completion date | March 30, 2015 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 2 Years |
Eligibility |
- INCLUSION CRITERIA: Infants will be selected for inclusion in each study on the basis of age, gestational status (i.e., full-term vs. pre-term birth), visual normality, and general health status. The initial group will be recruited to participate within two weeks on either side of their first birthday (12 months of age). Equal numbers of males and females will be recruited to participate. If the sample participating in either experiment fails to perform in the manner expected, additional participants will be recruited at older test ages to identify when in the course of development such behavioral guidance emerges. As successive test ages will be separated by 6 month intervals, independent samples of 18-, then 24-month-old children will be recruited until the expected pattern of adaptive actions is observed (cf. Fossberg, et al., 1992). EXCLUSION CRITERIA: Infants with a gestational age of less than 36 weeks, and/or those with histories of severe perinatal complications, visual abnormalities, or congenital developmental disorders will not be recruited for participation. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
United States,
Adolph KE. Learning in the development of infant locomotion. Monogr Soc Res Child Dev. 1997;62(3):I-VI, 1-158. — View Citation
Baillargeon R. Representing the existence and the location of hidden objects: object permanence in 6- and 8-month-old infants. Cognition. 1986 Jun;23(1):21-41. — View Citation
Bornstein MH, Kessen W, Weiskopf S. Color vision and hue categorization in young human infants. J Exp Psychol Hum Percept Perform. 1976 Feb;2(1):115-29. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |